BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 5:16:00 PM | Browse: 545 | Download: 312
Publication Name World Journal of Gastroenterology
Manuscript ID 6801
Country/Territory Singapore
2013-10-29 10:47
Peer-Review Started
2013-10-30 07:59
To Make the First Decision
2013-12-26 11:35
Return for Revision
2013-12-27 15:36
2014-01-13 15:15
Second Decision
2014-04-09 08:15
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-09 09:02
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-05-14 15:46
Publish the Manuscript Online
2014-05-28 11:45
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Topic Highlights
Article Title MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: Current status and future prospects
Manuscript Source Invited Manuscript
All Author List Yi Lin Jane Tan and Wei Ning Chen
Funding Agency and Grant Number
Corresponding author Wei Ning Chen, Professor, School of Chemical and Biomedical Engineering, College of Engineering, Nanyang Technological University, 62 Nanyang Drive, Singapore 637459, Singapore. wnchen@ntu.edu.sg
Keywords Hepatitis B virus; Hepatitis B virus X protein; Hepatocellular carcinoma; Mechanisms; MicroRNAs; Profiling
Core Tip Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is a complex cancer of the liver stemming from the long term infection of the virus. MiRNAs are found to be involved in a multitude of events, ranging from the diagnosis, pathogenesis as well as possibly in the treatment of this cancer. This review explores the current knowledge in understanding the role of miRNAs in HBV-related HCC, and how it is able to regulate, or be regulated, such that important cellular processes may be affected.
Publish Date 2014-05-28 11:45
Citation Tan YLJ, Chen WN. MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: Current status and future prospects. World J Gastroenterol 2014; 20(20): 5973-5986
Url http://www.wjgnet.com/1007-9327/full/v20/i20/5973.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i20.5973
Full Article (PDF) WJG-20-5973.pdf
Full Article (Word) WJG-20-5973.doc
Manuscript File 6801-Review.docx
Answering Reviewers 6801-Answering reviewers.pdf
Copyright License Agreement 6801-Copyright assignment.pdf
Peer-review Report 6801-Peer review(s).pdf
Scientific Editor Work List 6801-Scientific editor work list.doc